How Abbott and Cordis are working to change the interventional vascular business

Let’s get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech’s stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline.

This week’s Newmarker’s Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed.

Subscribe to this podcast on all major podcast applications!